Methenamine Hippurate Tablets
» Methenamine Hippurate Tablets contain not less than 95.0 percent and not more than 105.0 percent of the labeled amount of methenamine hippurate (C6H12N4·C9H9NO3).
Packaging and storage— Preserve in well-closed containers.
Labeling— When more than one Dissolution test is given, the labeling states the Dissolution test used only if Test 1 is not used.
Identification— A portion of finely powdered Tablets responds to the Identification test under Methenamine Hippurate.
Dissolution 711—
test 1—
Medium: water; 900 mL.
Apparatus 2: 100 rpm.
Time: 30 minutes.
Standard solution— Dissolve an accurately weighed quantity of USP Methenamine Hippurate RS in water to obtain a solution having a known concentration of about 22 µg per mL.
Procedure— Determine the amount of C6H12N4·C9H9NO3 dissolved by employing UV absorption, using a suitable spectrophotometer, at the wavelength of maximum absorbance at about 227 nm on filtered portions of the solution under test, suitably diluted with water, if necessary, in comparison with the Standard solution.
Tolerances— Not less than 80% (Q) of the labeled amount of C6H12N4·C9H9NO3 is dissolved in 30 minutes.
test 2— If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: water; 900 mL.
Apparatus 2: 50 rpm.
Time: 60 minutes.
Standard solution and Procedure— Proceed as directed for Test 1.
Tolerances— Not less than 80% (Q) of the labeled amount of C6H12N4·C9H9NO3 is dissolved in 60 minutes.
Uniformity of dosage units 905: meet the requirements.
Assay— Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 700 mg of methenamine hippurate, to a 250-mL conical flask. Add 50 mL of alcohol, then add thymolphthalein TS, and titrate with 0.1 N sodium hydroxide VS. Perform a blank determination on a mixture of 50 mL of alcohol and 20 mL of water, and make any necessary correction. Each mL of 0.1 N sodium hydroxide is equivalent to 31.94 mg of methenamine hippurate (C6H12N4·C9H9NO3).
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Behnam Davani, Ph.D., M.B.A.
Senior Scientist
1-301-816-8394		 (MDAA05) Monograph Development-Antivirals and Antimicrobials
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientist
1-301-816-8106		 (BPC05) Biopharmaceutics05
USP32–NF27 Page 2922
Pharmacopeial Forum: Volume No. 31(1) Page 63